A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children
PHASE3
The purpose of this trial is to demonstrate the acceptable safety profile a...
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
PHASE3
The purpose of this study is to assess, in adults 18 years of age and above...
Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years
PHASE3
The purpose of this study was to demonstrate the non-inferior HAI immune re...
Status
Terminated
Location
Birmingham Pediatric Associates Site Number : 8400023